ATLANTA – Two prominent researchers from Georgia State University’s Institute for Biomedical Sciences have been named to the prestigious Highly Cited Researchers 2024 list, earning a spot among the top 1 percent of scientists globally. This recognition marks a significant achievement in their fields, acknowledging their extensive contributions to scientific research.
The Highly Cited Researchers list, compiled annually by Clarivate, identifies scholars whose published works have gained wide recognition, influencing advancements across their disciplines. Researchers who make this list are chosen based on their citation impact, reflecting how often their work is referenced by peers. Over the past decade, the selected scientists’ papers have ranked in the top 1 percent for citation frequency within their respective fields, as tracked in the Web of Science database.
Andrew Gewirtz: A Visionary in Cross-Field Research
Andrew Gewirtz, a Regents’ Professor at Georgia State University, has once again earned a spot on the Highly Cited Researchers list, making it the seventh consecutive year he has been recognized in the cross-field category. Gewirtz is celebrated for his innovative work that transcends traditional academic boundaries, contributing to multiple disciplines simultaneously.
His research focuses on inflammatory diseases and their link to various chronic conditions, including cancer. Over the years, Gewirtz’s work has bridged gaps between microbiology, immunology, and biochemistry, making his contributions valuable to a wide array of scientific communities. The recognition of his cross-field impact underscores his ability to influence several areas of biomedical research, enhancing the understanding of how diseases develop and progress.
Notably, Gewirtz’s body of work continues to shape the landscape of chronic disease research. His publications regularly inspire follow-up studies and are essential readings for both aspiring scientists and established researchers alike.
Lanying Du: A Pioneer in Microbial Research
Lanying Du, a Distinguished University Professor in the same Institute, also secured her spot among the Highly Cited Researchers for 2024, making her an exemplary figure in biomedical research. Du’s recognition extends across several fields, with particular emphasis on microbiology and cross-field research, which she has been celebrated for in previous years as well.
Du’s research primarily explores the complex interactions between the human immune system and microbial pathogens. Her groundbreaking work has provided deep insights into how infections affect the body, guiding strategies for vaccine development and treatments for infectious diseases. Her focus on the microbiome has positioned her as one of the leaders in understanding the relationship between gut bacteria and overall health.
Her contributions are not limited to academic circles. Du’s findings have had a significant impact on healthcare practices, particularly in areas concerning infectious diseases and immune system responses. As a researcher who has consistently been ranked among the top 2 percent of scientists globally by Stanford University from 2021 to 2024, Du’s career is marked by exceptional contributions that continue to influence the scientific community worldwide.
A Global Impact on Science and Academia
According to Clarivate, the Highly Cited Researchers list includes 6,886 researchers from 59 countries, with a diverse representation across various scientific and social science fields. This recognition is awarded to only 1 in 1,000 researchers globally, highlighting the significant influence of those who make the list.
The selection process considers not just citation counts but also expert judgment. This means that researchers are evaluated for their broader impact within the scientific community—how their work has propelled innovation, inspired others, and shaped future directions in academia and technology. With their placements, Gewirtz and Du join an elite group of scientists who are recognized for their far-reaching influence.
For these researchers, the honor is not just a personal achievement but a testament to the value of their ongoing contributions. They are part of a larger global movement of scientists who continue to push the boundaries of knowledge and strive to solve some of the world’s most pressing health challenges.
- The Highly Cited Researchers 2024 list includes individuals from a variety of fields, including biomedical research, physics, chemistry, and social sciences.
- Clarivate’s list is based on both quantitative data, such as citation activity, and qualitative analysis to evaluate researchers’ global contributions.
Their recognition also highlights the growing importance of interdisciplinary work. Researchers who bridge gaps across fields often drive innovation that creates ripple effects in unexpected areas. This can lead to breakthroughs that may not have been possible within a single scientific discipline.
The Road to Recognition
The process of being named to the Highly Cited Researchers list is no easy feat. Researchers must consistently publish influential papers that resonate across the global scientific community. For Gewirtz and Du, this recognition reflects years of dedication to their craft, with each study pushing the envelope in biomedical research. Their impact is not only felt through citations but also in the way their work is applied in real-world healthcare and scientific advancements.
Both Gewirtz and Du have long been part of the Georgia State University community, where their research has fostered innovation within the Institute for Biomedical Sciences. Their work has drawn significant attention from both national and international academic institutions, making them invaluable assets to the broader scientific community.
